Despite advancements, cancer analysis faces several challenges. These include the heterogeneity of tumors, the complexity of genetic mutations, and the variability in patient responses to treatment. Additionally, the integration and interpretation of vast amounts of data from diverse sources require sophisticated computational tools and expertise.
